Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients
- PMID: 15577319
- DOI: 10.1097/00008390-200412000-00008
Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients
Abstract
This study was performed to analyse the behaviour, risk factors, prognosis and evolution of cutaneous melanoma in childhood and adolescence treated in a single institution. A retrospective study was performed between 1980 and 2000 of patients aged 18 years or younger followed at the Hospital do Cancer de Sao Paulo, Brazil. Data included demographic status, risk factors, clinical and histopathological characteristics of the primary and metastatic lesions, stage and follow-up. Seventeen female (53.1%) and 15 male (46.9%) patients were studied. Twelve patients (37.5%) were aged 12 years or younger. The trunk was the most common location (14 patients; 43.8%). Five patients (15.6%) had giant congenital melanocytic naevus, three (9.4%) had xeroderma pigmentosum and one (3%) had dysplastic melanocytic naevus. Nodular melanoma was the most frequent histological type and 43.8% had a thickness of more than 4 mm. Five of the 32 patients (15.6%) were lost to follow-up and 15 (46.9%) were alive at the last year's follow-up, 11 (34.4%) without disease and four (12.5%) with active disease. The 5-year overall survival was 64.34%. An overall survival of 11.71% was found in patients with visceral metastasis with or without cutaneous and/or lymph node involvement, whereas the corresponding value was 90.48% (P value=0.0002) in patients with only cutaneous and/or lymph node metastasis. Cutaneous melanomas are uncommon in the young and are seldom diagnosed in the early stages, perhaps due to a reluctance to accept this diagnosis in this age group. Prevention and early stage diagnosis depend upon the recognition that this disease is present in the young.
Similar articles
-
Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.Melanoma Res. 2002 Jun;12(3):271-8. doi: 10.1097/00008390-200206000-00011. Melanoma Res. 2002. PMID: 12140384
-
Differences in the diagnosis of primary cutaneous melanoma in the public and private healthcare systems in Joinville, Santa Catarina State, Brazil.An Bras Dermatol. 2018 Jul-Aug;93(4):507-512. doi: 10.1590/abd1806-4841.20185767. An Bras Dermatol. 2018. PMID: 30066755 Free PMC article.
-
Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients.J Am Acad Dermatol. 2002 Jun;46(6):874-9. doi: 10.1067/mjd.2002.120471. J Am Acad Dermatol. 2002. PMID: 12063484
-
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.Melanoma Res. 2007 Dec;17(6):393-9. doi: 10.1097/CMR.0b013e3282f05039. Melanoma Res. 2007. PMID: 17992123
-
Familial cutaneous melanoma.Melanoma Res. 1995 Dec;5(6):413-8. doi: 10.1097/00008390-199512000-00004. Melanoma Res. 1995. PMID: 8589615 Review.
Cited by
-
Neonatal congenital malignant melanoma with lymph node metastasis.J Clin Oncol. 2009 Jun 1;27(16):2726-8. doi: 10.1200/JCO.2008.20.7258. Epub 2009 Apr 6. J Clin Oncol. 2009. PMID: 19349539 Free PMC article. No abstract available.
-
Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.BMC Cancer. 2010 Jun 5;10:260. doi: 10.1186/1471-2407-10-260. BMC Cancer. 2010. PMID: 20525386 Free PMC article.
-
Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.Int J Mol Sci. 2015 Apr 22;16(4):8988-96. doi: 10.3390/ijms16048988. Int J Mol Sci. 2015. PMID: 25913378 Free PMC article.
-
[Malignant melanoma in children and adolescents].Pathologe. 2007 Nov;28(6):437-44. doi: 10.1007/s00292-007-0938-2. Pathologe. 2007. PMID: 17874108 German.
-
Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):176-189. doi: 10.25259/IJDVL_431_19. Indian J Dermatol Venereol Leprol. 2021. PMID: 33769755
MeSH terms
LinkOut - more resources
Full Text Sources
Medical